LOVE.CN - Cannara Biotech Inc.
| Previous Close | 0.1650 |
| Open | 0.1650 |
| Bid | 0.1400 x 0 |
| Ask | 0.1450 x 0 |
| Day's Range | 0.1250 - 0.1700 |
| 52 Week Range | 0.0500 - 0.2050 |
| Volume | 2,211,913 |
| Avg. Volume | 479,024 |
| Market Cap | 97.268M |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0120 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce
Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce
- CNW Group
Cannara Biotech Submits Site Evidence Package to Health Canada for its Quebec Facility
VANCOUVER , Sept. 12, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (LOVE.CN) (OTCQB:LOVFF) (8CB.F), an emerging vertically integrated cannabis company focused on indoor cultivation and sale of premium cannabis and cannabis-infused products, announced it has submitted to Health Canada its site evidence package for Phase One of the Company's cultivation and processing facility in Farnham, Quebec . With construction recently completed, Phase One consists of 170,000 square feet, of which 110,000 is dedicated to indoor cultivation with a capacity of 20,000 kg of premium dried cannabis once the cultivation license is granted. The facility is situated on 27-acres of land located 45 minutes from Montreal and both the facility and the license are held through wholly owned subsidiaries of Cannara Biotech Inc.
- CNW Group
Cannara Announces Appointment of New Chief Operating Officer
Cannara Announces Appointment of New Chief Operating Officer
- CNW Group
OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing
OTCQB Venture Company Investor Presentations Now Available for On-Demand Viewing
- PR Newswire
Cannara Biotech to Webcast Live at VirtualInvestorConferences.com August 1
Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com VANCOUVER, British Columbia , ...
- CNW Group
Live OTCQB Venture Company Investor Conference August 1st
Live OTCQB Venture Company Investor Conference August 1st
- CNW Group
Cannara Biotech Inc. Reports Q3 2019 Results
VANCOUVER , July 25, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (OTCQB:LOVFF), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried premium cannabis and cannabis-infused products, today announced financial results for the three month and nine month periods ended May 31, 2019. Closed a Global shopCBD.com Inc. financing in excess of $8 million to support the launch of the online e-commerce platform for the sale and distribution, in the US, of hemp-based CBD products. Subsequent to the quarter, the Company further strengthened its balance sheet with a $2.1 million private placement.
- CNW Group
Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares
Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares
- CNW Group
Horizons ETFs Rebalances Marijuana-Focused ETFs
Horizons ETFs Rebalances Marijuana-Focused ETFs
- Market Exclusive
Cannabis Stock News Daily Roundup May 28
CannTrust Holdings (TSX: TRST) (NYSE: CTST) has launched a cannabis education portal together with Well.ca. The resource is available to Ontario residents through Well.ca with additional provinces to launch soon. Well.ca will serve as a resource and education center for those interested in exploring medical cannabis, leveraging content, insights and expertise from CannTrust's medical business. […]The post Cannabis Stock News Daily Roundup May 28 appeared first on Market Exclusive.
- CNW Group
Cannara Biotech Appoints Dr. Sara May to its Board of Directors
VANCOUVER , May 24, 2019 /CNW/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (CNBTF), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Dr. Sara May , PhD. Dr. May is recognized as an expert in the medical cannabis sector and will bring additional skill sets and help strengthen the Company's Board.
- PR Newswire
Cannara Biotech Commences Trading on the OTCQB Market in the United States
VANCOUVER, May 15, 2019 /PRNewswire/ - Cannara Biotech ("Cannara" or the "Company") (LOVE.CN) (8CB.F) (CNBTF), an emerging vertically integrated cannabis company focused on the cultivation and sale of cannabis and cannabis-infused products to the Canadian and international markets, today announced its common shares are listed for trading on the OTCQB® Venture Market under the trading symbol "CNBTF". The OTC operates financial markets for approximately 10,000 U.S. and global securities. "Cannabis and hemp-CBD markets are global markets, with customers, vendors and investors domiciled across all major industrial nations," said Zohar Krivorot, President and CEO of Cannara.
- GlobeNewswire
PSIQ ANNOUNCES RESELLER AGREEMENT WITH CANNARA BIOTECH SUBSIDIARY SHOPCBD.COM TO MARKET AND SELL ELITES CBD PRODUCT LINE WITHIN THE UNITED STATES
SUNRISE, Fla., April 30, 2019 -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), has.